|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/7048 | |
| A61P 33/14 | |||
| A61P 27/02 |
| (11) | Number of the document | 2455085 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12152476.3 |
| Date of filing the European patent application | 2006-09-29 | |
| (97) | Date of publication of the European application | 2012-05-23 |
| (45) | Date of publication and mention of the grant of the patent | 2017-05-10 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 0510025 | 2005-09-30 | FR | |
| 725320 P | 2005-10-12 | US | |
| 818316 P | 2006-07-05 | US |
| (72) |
Kaoukhov, Alexandre, FR
Villard, Christophe, FR
Bouissou, Philippe, FR
|
| (73) |
Galderma S.A.,
Zugerstrasse 8, 6330 Cham,
CH
|
| (54) | TOPICAL USE ON THE EYE OF IVERMECTIN, IN THE TREATMENT OF OPHTHALMIC PATHOLOGIES |
| TOPICAL USE ON THE EYE OF IVERMECTIN, IN THE TREATMENT OF OPHTHALMIC PATHOLOGIES |